These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 305530

  • 1. [Immunotherapy of malignant diseases. A way towards the goal?].
    Riethmüller G.
    MMW Munch Med Wochenschr; 1978 Feb 10; 120(6):161-2. PubMed ID: 305530
    [No Abstract] [Full Text] [Related]

  • 2. Immunotherapy of human cancer.
    Hersh EM, Gutterman JU, Mavligit GM.
    Adv Intern Med; 1977 Feb 10; 22():145-85. PubMed ID: 65906
    [No Abstract] [Full Text] [Related]

  • 3. [Current status of immunotherapy of malignant tumors].
    Flad HD, Betzler M, Herfarth C.
    Chirurg; 1979 Jan 10; 50(1):11-5. PubMed ID: 367730
    [No Abstract] [Full Text] [Related]

  • 4. Immunotherapy from malignant disease.
    Goodnight JE, Morton DL.
    Annu Rev Med; 1978 Jan 10; 29():231-83. PubMed ID: 348035
    [No Abstract] [Full Text] [Related]

  • 5. [Is immunotherapy useful in bronchial carcinoma?].
    Geraint JD.
    Schweiz Med Wochenschr; 1977 Apr 02; 107(13):421-2. PubMed ID: 300502
    [No Abstract] [Full Text] [Related]

  • 6. Immunotherapy of malignant melanoma.
    Terry WD.
    N Engl J Med; 1980 Nov 13; 303(20):1174-5. PubMed ID: 6999351
    [No Abstract] [Full Text] [Related]

  • 7. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
    Mathe G.
    Comp Immunol Microbiol Infect Dis; 1980 Nov 13; 3(4):407-32. PubMed ID: 6451350
    [No Abstract] [Full Text] [Related]

  • 8. Adjuvant immunotherapy.
    Goodnight JE, Morton DL.
    Int Adv Surg Oncol; 1978 Nov 13; 1():53-83. PubMed ID: 399764
    [Abstract] [Full Text] [Related]

  • 9. Cancer immunotherapy.
    Richman SP, Gutterman JU, Hersh EM.
    Can Med Assoc J; 1979 Feb 03; 120(3):322-4, 329. PubMed ID: 371776
    [Abstract] [Full Text] [Related]

  • 10. BCG as adjuvant immunotherapy for neoplasia.
    Hersh EM, Gutterman JU, Mavligit GM.
    Annu Rev Med; 1977 Feb 03; 28():489-515. PubMed ID: 324372
    [No Abstract] [Full Text] [Related]

  • 11. Improving the body's anticancer system.
    Kent S.
    Geriatrics; 1980 Feb 03; 35(2):122-9. PubMed ID: 7356587
    [No Abstract] [Full Text] [Related]

  • 12. Immune modulating therapy in gastrointestinal cancer.
    Chachoua A, Green M, Muggia FM.
    Am J Gastroenterol; 1986 Aug 03; 81(8):623-8. PubMed ID: 2426941
    [No Abstract] [Full Text] [Related]

  • 13. Immunotherapy for malignant disease.
    Med Lett Drugs Ther; 1976 Sep 24; 18(20):83-4. PubMed ID: 1066519
    [No Abstract] [Full Text] [Related]

  • 14. [Immunotherapy today. II. Immunostimulating therapy].
    D'Amelio R.
    Riv Med Aeronaut Spaz; 1978 Sep 24; 41(1):75-114. PubMed ID: 93770
    [No Abstract] [Full Text] [Related]

  • 15. Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
    Theilen GH, Hills D.
    J Am Vet Med Assoc; 1982 Nov 15; 181(10):1134-41. PubMed ID: 6757216
    [No Abstract] [Full Text] [Related]

  • 16. Immunological response in patients receiving Corynebacterium parvum therapy.
    Osborn DE, Castro JE.
    Clin Oncol; 1977 Jun 15; 3(2):155-64. PubMed ID: 872468
    [No Abstract] [Full Text] [Related]

  • 17. Immunotherapy of cancer.
    Holmes EC, Morton DL, Eilber FR.
    West J Med; 1977 Feb 15; 126(2):102-9. PubMed ID: 322390
    [Abstract] [Full Text] [Related]

  • 18. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM, Bartlett GL, Kreider JW, Biro TG, Kontra J.
    Cancer Res; 1979 Dec 15; 39(12):4838-42. PubMed ID: 498111
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy for gynecologic malignancies.
    Cohen CJ, Deppe G.
    Prog Clin Biol Res; 1981 Dec 15; 70():371-4. PubMed ID: 7031696
    [No Abstract] [Full Text] [Related]

  • 20. Active non-specific immunotherapy of experimental tumours.
    Silobrcić V.
    Folia Biol (Praha); 1980 Dec 15; 26(3):145-66. PubMed ID: 6998756
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.